Charlottesville, VANCT06053255Now EnrollingIRB Ready

Sacroiliitis Clinical Trial in Charlottesville, VA

Access cutting-edge sacroiliitis treatment through this clinical trial at a research site in Charlottesville. Study-provided care at no cost to qualified participants.

Sponsored by FUSMobile Inc.

Quick Self-Assessment

See if you qualify for this Charlottesville location

Preparing your pre-screening questions…

Expert Care in Charlottesville

Access sacroiliitis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related sacroiliitis treatment provided free

Apply for This Charlottesville Location

Check if you qualify for this sacroiliitis clinical trial in Charlottesville, VA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Charlottesville

    Convenient for VA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Charlottesville site if eligible
  4. 4Begin participation

About This Sacroiliitis Study in Charlottesville

The Neurolyser XR is a device used to deliver high-intensity focused ultrasound for the ablation of the lateral sacral branch nerve in patients with Sacroiliitis.

Sponsor: FUSMobile Inc.

Who Can Participate

Inclusion Criteria

Men and women aged 18 and older
Patients who are able and willing to give consent and able to attend all study visits.
Patients who are able to communicate with the treating physician.
Patients must have chronic lower back pain (LBP) attributed to degenerative sacroiliitis diagnosed by a pain physician using the following guidelines:
At least 1 positive sacroiliac joint provocation test (Gaeslen's test, FABER (Patrick's test), and pelvic rock)
Back pain predominantly below L5
50% relief following either sacroiliac joint (SI) joint injection and/or lateral branch blocks corresponding to the expected duration of the medication utilized. (i.e SI joint injection-expected pain relief duration of steroid, lateral branch blocks-expected pain relief duration of local anesthetic utilized).
All other possible sources of low back pain have been ruled out as the primary pain generator, including but not limited to: the intervertebral discs, bone fracture, the zygapophyseal joints, the hip joint, symptomatic spondylolisthesis, tumor, and other regional soft tissue structures (this is done by physical exam, medical history, and MRI/CT/X-ray as required)
Patients with NRS (0-10 scale) LBP average score ≥ 4
Patients with chronic LBP for at least 12 months.
Patients with Oswestry Disability Questionnaire (ODQ) for LBP score \> 40%

Exclusion Criteria

Patients on dialysis
Patients with evidence of lumbosacral radiculopathy on MRI, CT or physical exam findings, including radicular leg pain (symptomatic moderate or severe foraminal or central canal stenosis).
Spinal pathology that may impede recovery such as spina bifida occulta, grade II or higher.
Spondylolisthesis at L5/S1, or scoliosis
Patients with radiofrequency ablation (RF/RFA) treatment for sacroiliitis LBP
Patients with bilateral sacroiliitis LBP
Patients with previous low back surgery
Patients who are pregnant
Patients with existing malignancy
Patients with allergies to relevant anesthetics
Patients with motor deficit or any other indication for surgical intervention
Patients with contraindications for MRI
Patients with an acute medical condition (e.g., pneumonia, sepsis, systemic infection, uncontrolled immunosuppression-AIDS, cancer, DM) that is expected to hinder them from completing this study.
Patients with unstable cardiac status including:
Unstable angina pectoris on medication
Patients with documented myocardial infarction less than 40 days prior to protocol enrolment
Patients with Severe Congestive Heart Failure, New York Heart Association (NYHA) class 4.
Patients on anti-arrhythmic drugs or with uncontrolled and/or untreated arrhythmia status
Patients with severe cerebrovascular disease (CVA within last 6 months)
Patients with severe hypertension (diastolic BP \> 100 on medication)
Patient Body Mass Index \> 45 or \<20
Patients with known intolerance or allergies to the MRI contrast agent (e.g. Gadolinium or Magnevist) including advanced kidney disease
Patients with an active infection or severe hematological, neurological, or other uncontrolled disease.
The patient is unable to communicate with the investigator and staff.
Patients who are not able or willing to tolerate the required prolonged stationary position during treatment (approximately 2 hours)
Patient with acute pelvic inflammatory conditions
Ongoing/ unresolved Worker's compensation, injury litigation, military medical board, or disability remuneration claims
Morphine Milligram Equivalents (MME) \> 60 per 24 hrs.
Patients with platelets \< 100.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Charlottesville?

Yes, this clinical trial (NCT06053255) has an active research site in Charlottesville, VA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Sacroiliitis Treatment Options in Charlottesville, VA

If you're searching for sacroiliitis treatment options in Charlottesville, VA, this clinical trial (NCT06053255) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Charlottesville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sacroiliitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all sacroiliitis clinical trials near you to find additional studies recruiting in your area.

More Osteogenesis Imperfecta Trials in Charlottesville, VA

See all osteogenesis imperfecta clinical trials recruiting in Charlottesville — not just this study.

Browse Osteogenesis Imperfecta Trials in Charlottesville →

Browse More Trials by Condition

Osteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Charlottesville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Charlottesville, VA